Trial Outcomes & Findings for A Pilot Study of Demand Valve Oxygen Inhalation Therapy for Cluster Headache (NCT NCT01298921)

NCT ID: NCT01298921

Last Updated: 2019-07-11

Results Overview

Headache response after 30 minutes of oxygen treatment. Headache response is defined as a reduction in headache pain intensity from moderate, severe, or very severe pain to mild or no pain.

Recruitment status

TERMINATED

Study phase

PHASE1

Target enrollment

4 participants

Primary outcome timeframe

30 minutes

Results posted on

2019-07-11

Participant Flow

After the enrollment of 4 participants in this study, the PI left Geisinger and the study was terminated. Geisinger does not have any details regarding which Arm/Group participants completed. Therefore, 0 was added as the enrollment for each group.

Participant milestones

Participant milestones
Measure
Continous Flow Oxygen
Oxygen : 100 percent continuous oxygen given via a non-rebreather facemask at 7 to 15 liters per minute for 20 minutes
Oxygen Demand Valve
Oxygen : A demand valve delivers oxygen to the user as soon as they try to inhale from an attached mask or mouth tube. As the user starts to inhale, the slight drop in pressure within the mouth piece or mask lifts a valve and starts the oxygen flow. If the user inhales more deeply, more oxygen will flow in response to the increased demand, hence the name demand valve. Unlike a constant flow O2 regulator, a demand valve has no flow meter or flow rate controls, but it is capable of delivering O2 from 0 to 160 liters per minute (LPM). When using a demand valve, O2 dosage is controlled by respiration rate
Overall Study
STARTED
0
0
Overall Study
COMPLETED
0
0
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Pilot Study of Demand Valve Oxygen Inhalation Therapy for Cluster Headache

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: 30 minutes

Population: Data cannot be found despite efforts to contact primary investigator. Per our current document retention policy, and the fact that the investigator, study staff, and record owner are no longer employed at our site, we do not have any collected data for pre-specified Primary and Secondary Outcome Measures to report in Outcome Measure data table(s).

Headache response after 30 minutes of oxygen treatment. Headache response is defined as a reduction in headache pain intensity from moderate, severe, or very severe pain to mild or no pain.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 5 to 60 minutes

Population: Data cannot be found despite efforts to contact primary investigator. Per our current document retention policy, and the fact that the investigator, study staff, and record owner are no longer employed at our site, we do not have any collected data for pre-specified Primary and Secondary Outcome Measures to report in Outcome Measure data table(s).

1. Percentage of patients with no pain after 30 minutes of treatment 2. Headache relief and pain free at other time points (5 to 60 minutes) 3. Reduction of autonomic symptoms at 30 minutes 4. Any difference in treatment response between episodic and chronic cluster headache patients (if patient #'s allow) 5. Rescue medication use 6. Cluster headache recurrence by 24 hours post oxygen treatments 7. Patient satisfaction with treatment response compared with prior oxygen treatment if have utilized8.Likelihood of choosing this technique again to treat a cluster headache attack

Outcome measures

Outcome data not reported

Adverse Events

Continous Flow Oxygen

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Oxygen Demand Valve

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Office of Research Compliance

Geisinger Health System

Phone: 570-214-9628

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place